# Trade Mark Journal No.2026/031 31 July 2026

## UK00004394786 29 May 2026 (5,42)

ATRIUM

International priority date claimed: 11 December 2025 (United States of America) (99543378)

Class 5
  Biological, medicinal and pharmaceutical preparations, namely, oligonucleotide-based therapeutics for the treatment of cardiovascular, cardiomyopathies, and heart muscle related diseases and disorders.
Class 42
  Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology.

Atrium Therapeutics, Inc.

Representative: Abion UK Limited